Compare BridgeBio Pharma Inc (BBIO) vs Nasdaq100 ETF (QQQ) Price & Performance

BridgeBio Pharma IncTrade

Nasdaq100 ETFTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Nasdaq100 ETF — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Nasdaq100 ETF trades at $722.81. Which is the better fit depends on your goals.

	BBIO	QQQ
Market Cap	$16.36B	—
Sector	Health	—
52-Week High	$90.17	$746.16
52-Week Low	$47.29	$558.34
Enterprise Value	$18.14B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBIO

BridgeBio beats Q2 estimates, confirms $1B+ 2026 sales goal and plans three product launches by 2027.Seeking Alpha · 22 hours agoBullish View details →

QQQ

JEPQ’s high yield comes with costly ordinary income taxes and capped gains, hurting taxable investors.24/7 Wall Street · 16 hours agoBearish Invesco QQQ ETF costs more than its cheaper clone QQQM despite identical holdings.24/7 Wall Street · 1 day agoNeutral JPMorgan's JEPQ ETF offers Nasdaq exposure with monthly income and less volatility.24/7 Wall Street · 3 days agoNeutral View details →

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.